{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:33:05Z","timestamp":1777044785173,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.colsurfb.2015.07.021","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T19:47:41Z","timestamp":1437162461000},"page":"50-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["In-vitro assessment of cytotoxicity of halloysite nanotubes against HepG2, HCT116 and human peripheral blood lymphocytes"],"prefix":"10.1016","volume":"135","author":[{"given":"Farrukh Rafiq","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Harris","family":"Shoaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mudassar","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soong Ho","family":"Um","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabia Ismail","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahkamal","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsana","family":"Dar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2015.07.021_bib0005","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/pi.2754","article-title":"Newly emerging applications of halloysite nanotubes: a review","volume":"59","author":"Du","year":"2010","journal-title":"Polym. Int."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0010","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/nn800259q","article-title":"Halloysite clay nanotubes for controlled release of protective agents","volume":"2","author":"Lvov","year":"2008","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1180\/0009855054040180","article-title":"Halloysite clay minerals \u2014 a review","volume":"40","author":"Joussein","year":"2005","journal-title":"Clay Miner."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0378-5173(02)00274-0","article-title":"Characterisation of halloysite for use as a microtubular drug delivery system","volume":"243","author":"Levis","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0025","unstructured":"Chi Shi Zhi (Halloysite, Kaolin)\u2014Chinese Herbal Medicine, in: Yin Yang House, 2014."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0030","first-page":"71","article-title":"Optimization of diclofenac sodium profile from halloysite nanotubules","volume":"62","author":"Krejcova","year":"2013","journal-title":"Ceska Slov. Farm."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0378-5173(02)00702-0","article-title":"Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride","volume":"253","author":"Levis","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jps.21814","article-title":"A ceramic drug delivery vehicle for oral administration of highly potent opioids","volume":"99","author":"Forsgren","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0045","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1186\/1556-276X-6-608","article-title":"Functionalized halloysite nanotube-based carrier for intracellular delivery of antisense oligonucleotides","volume":"6","author":"Shi","year":"2011","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clay.2011.12.001","article-title":"The anti-inflammatory properties of halloysite","volume":"57","author":"Cornejo-Garrido","year":"2012","journal-title":"Appl. Clay Sci."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0055","unstructured":"Refusal Details as Recorded in OASIS by FDA for Refusal FS2-1092363-7\/1\/24, in: Import Refusal Report-US Food and Drug Adminitration, 2009."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0060","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1021\/bm9014446","article-title":"Cytocompatibility and uptake of halloysite clay nanotubes","volume":"11","author":"Vergaro","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1142\/S1793292007000441","article-title":"Clay nanotubes for encapsulation and sustained release of drugs","volume":"02","author":"Veerabadran","year":"2007","journal-title":"Nano"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.envres.2014.12.024","article-title":"Toxicological evaluation of clay minerals and derived nanocomposites: a review","volume":"138","author":"Maisanaba","year":"2015","journal-title":"Environ. Res."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0075","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1166\/jnn.2011.3194","article-title":"Natural nanocontainer for the controlled delivery of glycerol as a moisturizing agent","volume":"11","author":"Suh","year":"2011","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-012-1137-5","article-title":"Cytotoxicity evaluation of nanoclays in human epithelial cell line A549 using high content screening and real-time impedance analysis","volume":"14","author":"Verma","year":"2012","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0085","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1039\/C4EN00135D","article-title":"Toxicity of halloysite clay nanotubes in vivo: a Caenorhabditis elegans study","volume":"2","author":"Fakhrullina","year":"2015","journal-title":"Environ. Sci. Nano"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.colsurfb.2013.06.056","article-title":"Anti-inflammatory and anti-bacterial activity, and cytotoxicty of halloysite surfaces","volume":"111C","author":"Cervini-Silva","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0095","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/cjoc.201200657","article-title":"Halloysite nanotubes, a multifunctional nanovehicle for anticancer drug delivery","volume":"30","author":"Guo","year":"2012","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0100","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijpharm.2014.12.004","article-title":"Pharmaceutical properties of supramolecular assembly of co-loaded cardanol\/triazole-halloysite systems","volume":"478","author":"Massaro","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0105","first-page":"622","article-title":"Toxicity and genotoxicity of nano-SiO2 on human epithelial intestinal HT-29 line cell","volume":"56","author":"Sergent","year":"2012","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0110","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1021\/es900754q","article-title":"In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells","volume":"43","author":"Kawata","year":"2009","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/17435390.2011.552811","article-title":"Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration","volume":"6","author":"Schleh","year":"2012","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0120","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1038\/mtna.2013.2","article-title":"Protection and systemic translocation of siRNA following oral administration of chitosan\/siRNA nanoparticles","volume":"2","author":"Ballarin-Gonzalez","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10616-009-9193-0","article-title":"Cytogenetic effects of nine Helichrysum taxa in human lymphocytes culture","volume":"59","author":"Eroglu","year":"2009","journal-title":"Cytotechnology"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0130","doi-asserted-by":"crossref","first-page":"11350","DOI":"10.1021\/la801367j","article-title":"Particle size determination using TEM: a discussion of image acquisition and analysis for the novice microscopist","volume":"24","author":"Pyrz","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0135","series-title":"NIST-NCL Joint Assay Protocol, PCC-7","first-page":"2","article-title":"Measuring the size of nanoparticles using transmission electron microscopy (TEM)","author":"Bonevich","year":"2010"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/mutage\/gen020","article-title":"Supplementation of melatonin protects human lymphocytes in vitro from the genotoxic activity of melphalan","volume":"23","author":"Lialiaris","year":"2008","journal-title":"Mutagenesis"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0145","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1166\/jbn.2013.1495","article-title":"Hepatocyte cytotoxicity evaluation with zinc oxide nanoparticles","volume":"9","author":"Kim","year":"2013","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0150","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.msec.2014.03.022","article-title":"Effect of hydroxyapatite particle size, morphology and crystallinity on proliferation of colon cancer HCT116 cells","volume":"39","author":"Dey","year":"2014","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.colsurfb.2014.04.018","article-title":"Size- and dose-dependent toxicity of cellulose nanocrystals (CNC) on human fibroblasts and colon adenocarcinoma","volume":"119","author":"Hanif","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0160","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/mutage\/7.6.407","article-title":"A collaborative study on the improvement of the micronucleus test in cultured human lymphocytes","volume":"7","author":"Surralles","year":"1992","journal-title":"Mutagenesis"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0165","first-page":"325","article-title":"Halil Erhan, Determining mitotic index in peripheral lymphocytes of welders exposed to metal arc welding fumes","volume":"35","author":"Alakoc","year":"2011","journal-title":"Turkish J. Biol."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0170","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ieam.5630040117","article-title":"High-aspect ratio nanoparticles in nanotoxicology","volume":"4","author":"Journeay","year":"2008","journal-title":"Integr. Environ. Assess. Manag."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0175","first-page":"1","article-title":"Toxicity and environmental risks of nanomaterials: challenges and future needs","volume":"27","author":"Ray","year":"2009","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-61779-080-5_19","article-title":"Cellular chemosensitivity assays: an overview","volume":"731","author":"Sumantran","year":"2011","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0185","series-title":"Pharmaceutical Perspectives of Cancer Therapeutics","first-page":"49","article-title":"Anticancer drug development","author":"Narang","year":"2009"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.colsurfb.2012.11.046","article-title":"PST-Gold nanoparticle as an effective anticancer agent with immunomodulatory properties","volume":"104","author":"Joseph","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0195","unstructured":"United States Pharmacopeia and National Formulary (USP 32-NF 27), in: Uniformity of Dosage Units, United States Pharmacopeia Convention, Rockville, MD, 2011."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0200","unstructured":"Tablets Obtained by Direct Compression, in: G. BASF (Ed.) Generic Drug Formulations, BASF, 2005."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0205","unstructured":"WHO, Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations, in: P. Development (Ed.), vol. 2014, World Health Organization, Tallin, Estonia, 2007, Workshop."},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0210","series-title":"Handbook of Pharmaceutical Excipients","first-page":"129","article-title":"Cellulose, Microcrystalline","year":"2009"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0215","series-title":"Modified-Release Drug Delivery Technology","first-page":"1","article-title":"Oral modified-release delivery systems","author":"Charman","year":"2003"},{"key":"10.1016\/j.colsurfb.2015.07.021_bib0220","unstructured":"Guidance for Industry and Other Stakeholders: Toxicological Principles for the Safety Assessment of Food Ingredients, REDBOOK 2000, in: U. FDA (Ed.), US Deparment of Health and Human Services, Silver Spring, MD 2007, pp. 286."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776515300552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776515300552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:28:38Z","timestamp":1760524118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776515300552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":44,"alternative-id":["S0927776515300552"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2015.07.021","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vitro assessment of cytotoxicity of halloysite nanotubes against HepG2, HCT116 and human peripheral blood lymphocytes","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2015.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}